CD274 and neoplasm: Therefore, our results indicated that apatinib might exert its inhibitory effects on NSCLC by targeting VEGFR2/STAT3/PD-L1 signaling in both NSCLC cells and tumor derived macrophages and partially restoring theactivation of T cells.